Studies from several cancers show that lncRNA H19 promotes EMT by downregulating E-cadherin through diverse molecular mechanisms, such as stimulating the Wnt/β-catenin signaling pathway [38], and acting as ceRNA for miRNAs [9, 39]. The gene discussed is H19; the disease is cancer.